Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AARTI DRUGS Gains 7%; BSE HEALTHCARE Index Up 0.0%
Thu, 22 Aug 10:0

AARTI DRUGS Gains 7%; BSE HEALTHCARE Index Up 0.0%Image source: peterschreiber.media/www.istockphoto.com

AARTI DRUGS share price has zoomed 7% and is presently trading at Rs 573.2.

Meanwhile, the BSE HEALTHCARE index is at 42,010.1 .

Among the top gainers in the BSE HEALTHCARE index today are HIKAL CHEMIC (up 3.6%) and AJANTA PHARMA (up 2.8%).

Procter & Gamble Health (down 3.0%) and GSK Pharma (down 2.1%) are among the top losers today.

Over the last one year, AARTI DRUGS has moved up from Rs 558.1 to Rs 573.2, registering a gain of Rs 15.1 (up 2.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 42,010.1, registering a gain of 49.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 131.0%), Glenmark Pharma (up 115.1%) and GSK Pharma (up 113.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,995.3 (up 0.1%).

The top gainers among the BSE Sensex today are Bharti Airtel (up 1.2%) and Asian Paints (up 0.7%). The most traded stocks in the BSE Sensex are Bharti Airtel and Tata Steel.

In the meantime, NSE Nifty is at 24,799.8 (up 0.1%). Grasim Industries and Tata Consumer Products are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 80,995.3, registering a gain of 15,779.2 points (up 24.2%).

AARTI DRUGS Financial Update...

AARTI DRUGS net profit fell 30.6% YoY to Rs 333 million for the quarter ended June 2024, compared to a profit of Rs 480 million a year ago. Net sales declined 16.0% to Rs 5,553 million during the period as against Rs 6,611 million in April-June 2023.

For the year ended March 2023, AARTI DRUGS reported 18.8% decrease in net profit to Rs 1,664 million compared to net profit of Rs 2,050 million during FY22. Revenue of the company grew 9.1% to Rs 27,161 million during FY23.

The current Price to earnings ratio of AARTI DRUGS, based on rolling 12 month earnings, stands at 33.6.


Equitymaster requests your view! Post a comment on "AARTI DRUGS Gains 7%; BSE HEALTHCARE Index Up 0.0%". Click here!